Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:47 AM
Study NCT ID:
NCT00483002
Status:
COMPLETED
Last Update Posted:
2012-05-11
First Post:
2007-06-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers
Detailed Description:
No sampling method will be applied to this study.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: